| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |